Neimeth International Pharmaceuticals Plc. (the Company) wishes to inform that at the Board of Directors meeting of 27^th January 2023, the Board approved the Unaudited Financial Statements for the period ended 31st December 2022 (2022 Q4) and same has been filed. 

Consequently, the Closed Period earlier announced on the trading in the Company’s shares by Insiders and connected persons, directly or indirectly shall remain until 24 hours after the 2022 Full Year Audited Financial Statements has been filed.